Who Buys Soframycin from India — 95 Importers Behind a $598.8K Market

The importation of Soframycin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.

Distributors: Entities like A. Baur & Co. (Pvt.) Ltd in Sri Lanka, which appears under multiple names in the top buyer list, function as primary distributors. They procure large volumes to supply local pharmacies, hospitals, and clinics. Their purchasing behavior is characterized by bulk orders to maintain a steady supply chain, ensuring product availability across the healthcare sector.

Government Procurement Agencies: Organizations such as the State Trading Organization PLC in the Maldives are involved in government procurement. They acquire pharmaceuticals through national tenders to supply public healthcare facilities. Their purchasing patterns are typically large-scale and periodic, aligning with government budget cycles and healthcare program needs.

Retail Chains and Hospital Groups: While specific entities in the top buyer list are not explicitly identified as retail chains or hospital groups, these segments generally procure Soframycin to meet patient demand. Their orders are based on consumption rates and inventory levels, often placing smaller, more frequent orders to manage stock efficiently.

Re-exporters and Contract Manufacturers: The data does not explicitly identify re-exporters or contract manufacturers among the top buyers. However, in the pharmaceutical trade, re-exporters purchase products for resale in other markets, and contract manufacturers may import active pharmaceutical ingredients or finished products for local packaging and distribution.

Sri Lanka:

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process: Importers must register with the NMRA, providing detailed product information, including composition, manufacturing process, and quality control measures. A local agent is required to facilitate the registration.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and the need for additional information.

4. Import Tariff/Duty for HS 30041090: Pharmaceutical products under this HS code are generally exempt from import duties, but a Value Added Tax (VAT) of 15% may apply.

Angola:

1. Drug Regulatory Authority: Agência Reguladora de Medicamentos e Tecnologias de Saúde (ARMED).

2. Import Registration Process: Importers must submit a dossier to ARMED, including product details, manufacturing licenses, and certificates of analysis. A local representative is mandatory.

3. Estimated Timeline for Registration: The process can take approximately 12 to 18 months, subject to the evaluation of the submitted documents.

4. Import Tariff/Duty for HS 30041090: Pharmaceuticals are subject to an import duty of 2% and a VAT of 5%.

Tanzania:

1. Drug Regulatory Authority: Tanzania Medicines and Medical Devices Authority (TMDA).

2. Import Registration Process: Importers must register their premises with TMDA and apply for an import permit at least six weeks prior to loading the consignment. Applications are lodged online through the trader portal. Compliance with guidelines for importation and exportation of pharmaceutical products is required. (tmda.go.tz)

3. Estimated Timeline for Registration: Processing is within seven days, provided all requirements are met. (tmda.go.tz)

4. Import Tariff/Duty for HS 30041090: Pharmaceuticals are generally exempt from import duties, but a VAT of 18% applies.

Seychelles:

1. Drug Regulatory Authority: Seychelles Medicines Regulatory Authority (SMRA).

2. Import Registration Process: Importers must obtain a license from SMRA, submitting product dossiers that include manufacturing details and quality certifications.

3. Estimated Timeline for Registration: The registration process usually takes 6 to 9 months.

4. Import Tariff/Duty for HS 30041090: Pharmaceuticals are exempt from import duties, but a VAT of 15% is applicable.

Zambia:

1. Drug Regulatory Authority: Zambia Medicines Regulatory Authority (ZAMRA).

2. Import Registration Process: Importers must register with ZAMRA, providing comprehensive product information and evidence of Good Manufacturing Practice (GMP) compliance.

3. Estimated Timeline for Registration: The process can take 9 to 12 months, depending on the complexity of the product and the completeness of the application.

4. Import Tariff/Duty for HS 30041090: Pharmaceuticals are generally exempt from import duties, but a VAT of 16% applies.

The demand for Soframycin in importing countries is influenced by several factors:

1. Disease Prevalence: Soframycin, an antibiotic used to treat bacterial infections, is essential in regions with high incidences of skin and soft tissue infections. In tropical climates, such conditions are prevalent, driving the need for effective topical antibiotics.

2. Government Healthcare Programs: Many importing countries have national healthcare programs that prioritize the availability of essential medicines. For instance, the inclusion of Soframycin in national formularies ensures its procurement and distribution through public health facilities.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased access to essential medicines. Countries are investing in healthcare infrastructure and supply chains to ensure that antibiotics like Soframycin are available to the general population.

4. WHO Essential Medicines List Procurement: Soframycin's inclusion in the WHO Model List of Essential Medicines underscores its importance. This designation encourages countries to procure and stock the medication, aligning with global health recommendations. (who.int)

5. Tender-Based Purchasing: Government and international organizations often use tender systems to procure medicines. This approach ensures competitive pricing and consistent supply, benefiting both suppliers and healthcare providers. The presence of 95 buyers across 36 countries indicates a robust market for Soframycin, with opportunities for suppliers to engage in tender processes and expand their reach.

The importation of Soframycin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.

Distributors: Entities like A. Baur & Co. (Pvt.) Ltd in Sri Lanka, which appears under multiple names in the top buyer list, function as primary distributors. They procure large volumes to supply local pharmacies, hospitals, and clinics. Their purchasing behavior is characterized by bulk orders to maintain a steady supply chain, ensuring product availability across the healthcare sector.

Government Procurement Agencies: Organizations such as the State Trading Organization PLC in the Maldives are involved in government procurement. They acquire pharmaceuticals through national tenders to supply public healthcare facilities. Their purchasing patterns are typically large-scale and periodic, aligning with government budget cycles and healthcare program needs.

Retail Chains and Hospital Groups: While specific entities in the top buyer list are not explicitly identified as retail chains or hospital groups, these segments generally procure Soframycin to meet patient demand. Their orders are based on consumption rates and inventory levels, often placing smaller, more frequent orders to manage stock efficiently.

Re-exporters and Contract Manufacturers: The data does not explicitly identify re-exporters or contract manufacturers among the top buyers. However, in the pharmaceutical trade, re-exporters purchase products for resale in other markets, and contract manufacturers may import active pharmaceutical ingredients or finished products for local packaging and distribution.

Sri Lanka:

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process: Importers must register with the NMRA, providing detailed product information, including composition, manufacturing process, and quality control measures. A local agent is required to facilitate the registration.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and the need for additional information.

4. Import Tariff/Duty for HS 30041090: Pharmaceutical products under this HS code are generally exempt from import duties, but a Value Added Tax (VAT) of 15% may apply.

Angola:

1. Drug Regulatory Authority: Agência Reguladora de Medicamentos e Tecnologias de Saúde (ARMED).

2. Import Registration Process: Importers must submit a dossier to ARMED, including product details, manufacturing licenses, and certificates of analysis. A local representative is mandatory.

3. Estimated Timeline for Registration: The process can take approximately 12 to 18 months, subject to the evaluation of the submitted documents.

4. Import Tariff/Duty for HS 30041090: Pharmaceuticals are subject to an import duty of 2% and a VAT of 5%.

Tanzania:

1. Drug Regulatory Authority: Tanzania Medicines and Medical Devices Authority (TMDA).

2. Import Registration Process: Importers must register their premises with TMDA and apply for an import permit at least six weeks prior to loading the consignment. Applications are lodged online through the trader portal. Compliance with guidelines for importation and exportation of pharmaceutical products is required. (tmda.go.tz)

3. Estimated Timeline for Registration: Processing is within seven days, provided all requirements are met. (tmda.go.tz)

4. Import Tariff/Duty for HS 30041090: Pharmaceuticals are generally exempt from import duties, but a VAT of 18% applies.

Seychelles:

1. Drug Regulatory Authority: Seychelles Medicines Regulatory Authority (SMRA).

2. Import Registration Process: Importers must obtain a license from SMRA, submitting product dossiers that include manufacturing details and quality certifications.

3. Estimated Timeline for Registration: The registration process usually takes 6 to 9 months.

4. Import Tariff/Duty for HS 30041090: Pharmaceuticals are exempt from import duties, but a VAT of 15% is applicable.

Zambia:

1. Drug Regulatory Authority: Zambia Medicines Regulatory Authority (ZAMRA).

2. Import Registration Process: Importers must register with ZAMRA, providing comprehensive product information and evidence of Good Manufacturing Practice (GMP) compliance.

3. Estimated Timeline for Registration: The process can take 9 to 12 months, depending on the complexity of the product and the completeness of the application.

4. Import Tariff/Duty for HS 30041090: Pharmaceuticals are generally exempt from import duties, but a VAT of 16% applies.

The demand for Soframycin in importing countries is influenced by several factors:

1. Disease Prevalence: Soframycin, an antibiotic used to treat bacterial infections, is essential in regions with high incidences of skin and soft tissue infections. In tropical climates, such conditions are prevalent, driving the need for effective topical antibiotics.

2. Government Healthcare Programs: Many importing countries have national healthcare programs that prioritize the availability of essential medicines. For instance, the inclusion of Soframycin in national formularies ensures its procurement and distribution through public health facilities.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased access to essential medicines. Countries are investing in healthcare infrastructure and supply chains to ensure that antibiotics like Soframycin are available to the general population.

4. WHO Essential Medicines List Procurement: Soframycin's inclusion in the WHO Model List of Essential Medicines underscores its importance. This designation encourages countries to procure and stock the medication, aligning with global health recommendations. (who.int)

5. Tender-Based Purchasing: Government and international organizations often use tender systems to procure medicines. This approach ensures competitive pricing and consistent supply, benefiting both suppliers and healthcare providers. The presence of 95 buyers across 36 countries indicates a robust market for Soframycin, with opportunities for suppliers to engage in tender processes and expand their reach.